BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18479317)

  • 1. Compelling or irrelevant? Using number needed to treat can help decide.
    Citrome L
    Acta Psychiatr Scand; 2008 Jun; 117(6):412-9. PubMed ID: 18479317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change.
    Martinez-ArĂ¡n A; Vieta E; Chengappa KN; Gershon S; Mullen J; Paulsson B
    Bipolar Disord; 2008 Jul; 10(5):566-79. PubMed ID: 18657241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
    Ketter TA; Citrome L; Wang PW; Culver JL; Srivastava S
    Acta Psychiatr Scand; 2011 Mar; 123(3):175-89. PubMed ID: 21133854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2007; 76(2):77-88. PubMed ID: 17230048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
    Citrome L; Stroup TS
    Int J Clin Pract; 2006 Aug; 60(8):933-40. PubMed ID: 16893436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for depression and bipolar disorder.
    Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidepressant treatment practice in the face of STAR*D and STEP-BD.
    Cassidy F
    Bipolar Disord; 2008 Dec; 10(8):973-4. PubMed ID: 19594512
    [No Abstract]   [Full Text] [Related]  

  • 9. Bipolar II disorder: current and future treatment options.
    El-Mallakh R; Weisler RH; Townsend MH; Ginsberg LD
    Ann Clin Psychiatry; 2006; 18(4):259-66. PubMed ID: 17162626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat.
    Gensini GF; Conti AA
    Ital Heart J; 2003 Feb; 4(2):80-3. PubMed ID: 12762269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression.
    Rucker J; Cook M
    J ECT; 2008 Dec; 24(4):272-4. PubMed ID: 18648320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME
    J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological challenges in psychiatric treatment adherence research.
    Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upping the ante on antidepressants.
    Malhi GS
    Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513
    [No Abstract]   [Full Text] [Related]  

  • 18. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.
    Djulbegovic B; Hozo I; Lyman GH
    MedGenMed; 2000 Jan; 2(1):E6. PubMed ID: 11104452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.